Boswellia SAP provides a standardized dose of Boswellia serrata oleogum resin extract, used in traditional medicine for centuries for a number of ailments related to acute and chronic inflammation. Boswellic acids, especially 11‑keto-β‑boswellic acid (KBA) and 3‑O‑acetyl-11‑keto- β‑boswellic acid (AKBA) are the main active constituents responsible for the anti-inflammatory effects of B. serrata, are specific inhibitors of 5‑lipoxygenase (5‑LOX), and thereby suppress leukotriene synthesis. Boswellia SAP can be used to maintain healthy inflammatory response and reduce pain associated with osteo‑ and rheumatoid arthritis. Boswellia SAP could be very useful in the management of inflammatory bowel diseases (IBD) and to improve quality of life in patients during the remission phase. In addition, Boswellia SAP could help improve lung and immune function in asthma patients. Boswellia SAP can also be used to reduce peritumoural brain oedema, support neurorecovery following traumatic brain injury (TBI), and potentially as an adjunctive support in cancer treatment. Evidence supports the use of Boswellia SAP for promoting clinical benefits in blood-glucose control and lipid metabolism in type 2 diabetic patients.
70% organic acid providing 35% boswellic acid380 mg
All ingredients listed for each Boswellia SAP lot number have been validated by an ISO 17025 accredited third-party laboratory for identity, potency, and purity.